Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Merck Millipore Introduces Magna™ Nuclear RIP Kits
Tuesday, August 05, 2014
Facilitates isolation and analysis of RNA molecules associated with chromatin.

Cancer Conference Poster Prize Winner
Friday, July 25, 2014
Katarzyna Grzes announced as the winner of the AMSBIO-Trevigen prize for the best poster.

EKF Diagnostics’ Growing Product Portfolio Highlighted at AACC 2014
Thursday, July 24, 2014
From early detection of ketosis to cancer mutation testing in whole blood.

New Data Using EKF PointMan™ Technology
Tuesday, July 22, 2014
New data suggest the possibility of a simple blood test for cancers.

ACD’s RNAscope® In Situ Hybridization Technology Gains Significant Traction
Wednesday, July 16, 2014
Highly sensitive and easy-to-use technology validated in over 100 papers in three years.

QIAGEN Launch of 14 New Cancer Gene Panels
Wednesday, July 16, 2014
QIAGEN introduces 14 new panels for targeted enrichment of up to 570 clinically-relevant genes, expands largest portfolio of panels for assessing cancer genes.

Olink Bioscience Introduces a 92-protein Biomarker Panel
Wednesday, July 02, 2014
Proseek® Multiplex Inflammation I 96x96 for inflammatory diseases.

SciGene Introduces Dual Temperature FISH Slide Incubator
Tuesday, July 01, 2014
CytoBrite Duo Slide Incubation system for performing FISH hybridization protocols.

GE Healthcare Launches Cytell™ Cell Imaging System
Wednesday, June 25, 2014
Streamlines data acquisition, analysis and visualization.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 653
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv